Behçet's disease complicated with thrombosis: a report of 93 Chinese cases

Xiuhua Wu1, Guohua Li, Xinxiang Huang

  • 1From the Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, 100730, China (XW, LW, YZ, WZ); Department of Nephrology, Inner Mongolia Hospital of Traditional Chinese Medicine, Hohhot, 010020, China (GL); Department of Rheumatology and Hematology, the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China, 530021 (XH); and MOE Key Laboratory of Protein Science, School of Life Sciences, Tsinghua University, Beijing, 100084, China (WL).

Medicine
|December 20, 2014
PubMed

Insights

Behçet

Area of Science:

  • Rheumatology
  • Vascular Medicine
  • Clinical Immunology

Background:

  • Behçet's disease (BD) is a multisystemic vasculitis with a propensity for thrombotic events.
  • Thrombosis is a significant complication of BD, impacting patient morbidity and mortality.

Purpose of the Study:

  • To investigate the clinical characteristics of thrombosis in patients with Behçet's disease.
  • To identify risk factors and patterns of thrombotic complications in BD.

Main Methods:

  • Retrospective review of medical records of 766 BD patients from 1993 to 2013.
  • Analysis of demographic, clinical, and laboratory data for patients who developed thrombosis.

Main Results:

  • 93 out of 766 BD patients (12.1%) developed thrombosis, predominantly venous (94.6%) and multiple (94.6%).
  • Extremity vein thrombosis was most common (86.0%), followed by vena cava (30.1%) and pulmonary thromboembolism (15.1%).
  • Male predominance for extremity vein thrombosis and female predominance for cerebral venous thrombosis (CVT) were observed. Active disease correlated with thrombotic events.

Conclusions:

  • Thrombosis in Behçet's disease is characterized by male predominance, multiplicity, and a predilection for venous sites.
  • Active disease necessitates aggressive immunosuppressive therapy to manage and prevent thrombotic complications.
  • Understanding these patterns aids in early diagnosis and tailored management strategies for BD patients at risk of thrombosis.

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
769
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
475
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
229
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
4
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.9K